TVGN (STOCKS)
Tevogen Bio Holdings Inc. Common Stock
$5.980000
+0.400000 (+7.17%)
Prev close: $5.580000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ryan Saadi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24.61M
- Employees
- 17
- P/E (TTM)
- -0.75
- P/B (TTM)
- -1.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.45 | $-2.04 | +0.5900 | +28.92% |
Financial Statements
| Revenues | -$195.62K |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $25.94M |
| Operating Expenses | $26.14M |
| Research and Development | $11.11M |
| Other Operating Expenses | $15.03M |
| Operating Income/Loss | -$26.14M |
| Income/Loss From Continuing Operations After Tax | -$26.28M |
| Income/Loss From Continuing Operations Before Tax | -$195.62K |
| Income Tax Expense/Benefit | $4.75K |
| Interest Income/Expense After Provision For Losses | -$195.62K |
| Interest Income/Expense Operating, Net | -$195.62K |
| Net Income/Loss | -$26.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$26.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$26.83M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $550.00K |
| Preferred Stock Dividends And Other Adjustments | $550.00K |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$8.08 |
| Diluted Earnings Per Share | -$8.08 |
| Basic Average Shares | 3,319,812 |
| Diluted Average Shares | 3,319,812 |
| Assets | $4.38M |
| Current Assets | $1.54M |
| Noncurrent Assets | $2.84M |
| Fixed Assets | $170.31K |
| Other Non-current Assets | $2.67M |
| Liabilities | $12.62M |
| Current Liabilities | $7.07M |
| Accounts Payable | $3.34M |
| Other Current Liabilities | $3.73M |
| Noncurrent Liabilities | $5.55M |
| Equity | -$8.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$8.23M |
| Liabilities And Equity | $4.38M |
| Net Cash Flow From Operating Activities | -$12.33M |
| Net Cash Flow From Operating Activities, Continuing | -$12.33M |
| Net Cash Flow From Investing Activities | $666.18K |
| Net Cash Flow From Investing Activities, Continuing | $666.18K |
| Net Cash Flow From Financing Activities | $11.66M |
| Net Cash Flow From Financing Activities, Continuing | $11.66M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$26.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.28M |
| Other Comprehensive Income/Loss | $0.00 |